Learn, Analyse & Invest
only with
only with
+91
Download Orca
Ishita Drugs & Industries Ltd.
Ishita Drugs & Inds.
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹24.23 Cr.
| EX-Date | Purpose |
|---|---|
| 13 08 2021 | Quarterly Results |
| 02 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results & Inter alia, 1. To consider increase in the Authorised Share Capital of the Company and consequent alteration in clause V (capital clause) of Memorandum of Association. 2.To consider the adoption of revised Articles of Association of the Company to align it with the regulations of Companies Act, 2013. 3. To consider the re-appointment of M/s Meenu Maheshwari & Associates, Practicing Company Secretary as the Secretarial Auditor of the Company for the year 2022-23. 5. To take on record Disclosure of Interest of Directors. |
| 13 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 12 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 12 11 2024 | Quarterly Results |
| 13 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 13 06 2025 | Interalia, to consider and approve the following matters: 1. To Update regarding the current business operations of the Company. 2. Any other matter with permission of the Chair. |
| 12 08 2025 | Quarterly Results |
| 11 11 2025 | Quarterly Results |
| 07 02 2026 | Quarterly Results |
News
